Imaging of common benign solid liver tumors

Journal Medical Libanais

Volumn 50, Issue 5-6, 2002, Pages 237-246

  Al Hawary, Mahmoud M ^a   Haddad, Maurice C ^a   Hourani, Mukbil H ^a   Birjawi, Ghina A ^a   Al Kutoubi, Aghiad O ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; HUMAN; LIVER ADENOMA; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ADENOMA, LIVER CELL; DIAGNOSTIC IMAGING; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA; HUMANS; LIVER NEOPLASMS;

EID: 1842733346     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975; 59: 999-1013.
2. Karhunen PJ. Benign hepatic tumors and tumor-like conditions in men. J Clin Pathol 1986; 152: 285-7.
3. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangioma of the liver with pathologic correlation. Radiographics 2000; 20: 379-97.
4. Nghiem H, Bogost GA, Ryan JA, Lund P, Freeny PC, Rice KM. Cavernous hemangiomas of the liver: enlargement over time. AJR 1997; 169: 137-40.
5. Mungovan JA, Cronan JJ, Vacarro J. Hepatic cavernous hemangiomas: lack of enlargement over time. Radiology 1994; 191: 111-13.
6. Valles C, Rene M, Gil M, Sanchez A, Narvaez JA, Hidalgo F. Giant cavernous hemangiomas of the liver: Atypical CT and MR findings. Eur Radiol 1996; 6: 448-50.
7. Wright TL, Venook AP, Millward-Sadler GH. Hepatic tumors. In: Millward-Sadler GH, Wright R, Arthur MJP, eds. Wright's Liver and Biliary Disease, vol. 2, 3rd ed. Philadelphia: WB Saunders, 1992: 1079-121.
8. Daralk JJ, Moshowitz M, Kattan KR. Calcifications in the liver. Radiol Clin North Am 1990; 18: 209-19.
9. Nelson RC, Chezmar JL. Diagnostic approach to hepatic hemangiomas. Radiology 1990; 176: 11-13.
10. Moody AR, Wilson SR. Atypical hepatic hemangioma: a suggestive sonographic morphology. Radiology 1993; 188: 413-17.
11. Whitehouse RW. Computed tomography attenuation measurements for the characterisation of hepatic hemangiomas. Br J Radiol 1991; 64: 1019-22.
12. Quinn SF, Benjami GC. Hepatic cavernous hemangiomas ; simple diagnostic sign with dynamic biphasic CT. Radiology 1992; 182: 545-8.
13. Leslie DF, Johnson CD, Johnson CM, Iistrup D, Harmsen W. Distinction between cavernous hemangiomas of the liver and hepatic metastasis: value of contrast enhancement patterns. AJR 1995; 164: 625-9.
14. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: Pathologic correlation With dynamic CT findings. Radiology 1997; 203: 121-5.
15. Hyun-Jung Jang, Byung In Choi, Tae Kyoung Kim et al. Atypical small hemangiomas of the liver: "Bright Dot" sign at two-phase spiral CT. Radiology 1998; 208: 543-8.
16. Tavitsainem M, Airksien T, Kreula J, Päivänsalo M. Fine needle aspiration biopsy of liver hemangioma. Acta Radiologica 1990; 31: 69-71.
17. Heilo A, Stenwig A. Liver hemangioma: US-guided 18-gauge core-needle biopsy. Radiology 1997; 204: 719-22.
18. Karen MH, Horton KM, Bluemke DA, Hurbon RH, Soyer P, Fisherman EK. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999; 19: 431-51.
19. Semelka RC, Sofka CM. Hepatic hemangiomas. Magn Reson Imaging Clin North Am 1997; 5 (20): 241-53.
20. Ohtomo K, Itai Y, Yoshikawa K, Kokubo T, Lio M. Hepatocellular carcinoma and cavernous hemangiomas: differentiation with MR imaging. Efficacy of T2 values at 0.35 and 1.5 T. Radiology 1988; 168: 621-3.
21. Itai Y, Ohtomo K, Furui S et al. Non-invasive diagnosis of small cavernous hemangiomas of the liver: advantage of MRI. AJR 1985; 145: 1195-9.
22. Birnbaum BA, Weinreb JC, Megibow AJ et al. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m labeled red blood cell SPECT. Radiology 1990; 176: 95-101.
23. Soyer P, Gueye C, Somveille E et al. MR diagnosis of hepatic metastasis from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient recalled echoe and unenhanced spin-echo image. AJR 1995: 1407-13.
24. Kudo M, Ikekubo K, Yamamoto K. Distinction between hemangioma of the liver and hepatocellular carcinoma: value of labeled RBC-SPET scanning. AJR 1989; 152 (12): 577-83.
25. Melonghlin MJ. Angiography of cavernous hemangiomas of the liver. AJR 1971; 113: 50-5.
26. Mathieu D, Vilgrain V, Mahfouz AE, Anglade MC, Vullierme MP, Deneys A. Benign liver tumors. Magn Reson Imaging Clin North Am 1997; 5: 255-88.
27. Wanless IR, Mawdsley C, Adams R et al. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194-200.
28. Di-Stasi M, Caturelli E, De-Sio I, Salmi A, Buscarini E, Buscarini L. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound 1996; 24: 345-50.
29. Buetow PC, Patongrag-Brown L, Buck J et al. Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics 1996; 16: 369-88.
30. Kehagias D, Moulopoulus L, Antoniou A et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 2001 ; 11: 202-12.
31. Caseiro-Alves F, Zins M, Mahfouz AE et al. Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 1996; 198: 889-92.
32. Ros PR. Radiologic-pathologic correlation in liver tumors. In: Ferruci JT, Stark DD (eds). Liver Imaging. Boston: Andover Medical Publishers, 1990: 137-53.
33. Shamsi K, Schepper A, Degryse H et al. Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 1993; 18: 32-8.
34. Wang LY, Wang JH, Lin ZY et al. Hepatic focal nodular hyperplasia: findings on color Doppler ultrasound. Abdom Imaging 1997; 22: 178-81.
35. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasila N. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 1986; 160: 53-8.
36. Procacci C, Fugazzola C, Cinquinino M et al. Contribution of CT characterization of focal nodular hyperplasia of the liver. Gastrointest Radiol 1992; 17: 63-73.
37. Van Hoe L, Baert A, Gryspeerdt S et al. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of non-cystic focal lesions. AJR 1997; 168: 1185-92.
38. Choi CS, Freeny PC. Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR 1998; 170: 391-5.
39. Vilgrain V, Flejou JF, Arrive L et al. Focal nodular hyperplasia: MR imaging and pathologic correlation. Radio-logy 1992; 184: 699-703.
40. Cherqui D, Rahmouni A, Charlotte F et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiologic and pathologic correlations. Hepatology 1995; 22: 1674-81.
41. Rummeny E, Weissleder R, Sironi S et al. Central scars in primary liver tumors: MR features, specificity and pathologic correlation. Radiology 1989; 171: 323-6.
42. Mortele KJ, Praet M, Van-Vlierberghe H, Kunnen M, Ros PR. CT and MR findings in focal nodular hyperplasia : radiologic-pathologic correlation. AJR 2000; 175: 687-92.
43. Siegelman ES, Outwater EK. Magnetic resonance imaging of focal and diffuse hepatic disease. Seminars in Ultrasound, CT and MRI 1998; 19: 2-34.
44. Casarella WJ, Knowles DM, Wolff M, Johnson PM. Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation. AJR 1978; 131: 393-402.
45. nd, Johnson CM et al. Focal nodular hyperplasia and hepatic adenoma: comparison of angiogaphy, CT, US and scintigraphy. Radiology 1985; 156: 593-5.
46. Mergo PJ, Ros PR. Benign lesions of the liver. Radiologic Clinics of North Amercia 1998; 36: 319-31.
47. Drane WE, Krasicky GA, Johnson DA. Radionuclide imaging of primary tumors and tumor-like conditions of the liver. Clin Nucl Med 1987; 12: 569-82.
48. Edmondson HA, Henderson B, Benton B. Liver cell adenomas associated with the use of oral contraceptives. N Engl J Med 1976; 294: 470-2.
49. Kawakatsu M, Filgrain V, Erlinger S et al. Disappearance of liver cell adenoma: CT and MR imaging. Abdom Imaging 1997; 22: 274-6.
50. Gordan SC, Reddy SC, Reddy KR, Livingston AS, Jeffers LJ, Schiff ER. Resolution of a contraceptive steroid induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 1986; 105: 547-9.
51. Graig GR. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology (2nd series), Washington, DC: Armed Forces Institue of Pathology, 1989.
52. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR 1994; 163: 113-16.
53. Goldstein HM, Neiman HL, Mena E, Bookstein JJ, Appelman HD. Angiographic findings in benign liver cell tumors. Radiology 1974; 110: 339-43.
54. Taylor HM, Ross PR. Hepatic imaging: an overview. Radiologic Clinics of North America 1998; 36: 237-45.
55. Leen E. The role of contrast-enhanced ultrasound in the characterization of focal liver lesions. European Radiology 2001; 11 (Suppl. 3): E27-E34.
56. Harisinghani M, Jhaveri K, Weissleder R et al. MRI contrast agents for evaluating focal hepatic lesions. Clinical Radiology 2001; 56: 714-25.